English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Circulating endothelial cells as biomarker for cardiovascular diseases.

Farinacci, M., Krahn, T., Dinh, W., Volk, H. D., Düngen, H. D., Wagner, J., et al. (2019). Circulating endothelial cells as biomarker for cardiovascular diseases. Research and Practice in Thrombosis and Haemostasis, 3(1), 49-58. doi:10.1002/rth2.12158.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/21.11116/0000-0002-E49B-E Version Permalink: http://hdl.handle.net/21.11116/0000-0003-4F59-2
Genre: Journal Article

Files

show Files
hide Files
:
3024284.pdf (Publisher version), 927KB
Name:
3024284.pdf
Description:
-
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
:
3024284_Suppl_1.tiff (Supplementary material), 9MB
Name:
3024284_Suppl_1.tiff
Description:
-
Visibility:
Public
MIME-Type / Checksum:
image/tiff / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-
:
3024284_Suppl_2.tiff (Supplementary material), 8MB
Name:
3024284_Suppl_2.tiff
Description:
-
Visibility:
Public
MIME-Type / Checksum:
image/tiff / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-
:
3024284_Suppl_3.docx (Supplementary material), 26KB
Name:
3024284_Suppl_3.docx
Description:
-
Visibility:
Public
MIME-Type / Checksum:
application/vnd.openxmlformats-officedocument.wordprocessingml.document / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-
:
3024284_Suppl_4.htm (Supplementary material), 25KB
Name:
3024284_Suppl_4.htm
Description:
-
Visibility:
Public
MIME-Type / Checksum:
application/x-tika-ooxml / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-
:
3024284_Suppl_5.docx (Supplementary material), 24KB
Name:
3024284_Suppl_5.docx
Description:
-
Visibility:
Public
MIME-Type / Checksum:
application/vnd.openxmlformats-officedocument.wordprocessingml.document / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-
:
3024284_Suppl_6.docx (Supplementary material), 25KB
Name:
3024284_Suppl_6.docx
Description:
-
Visibility:
Public
MIME-Type / Checksum:
application/vnd.openxmlformats-officedocument.wordprocessingml.document / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-

Locators

show

Creators

show
hide
 Creators:
Farinacci, M., Author
Krahn, T., Author
Dinh, W., Author
Volk, H. D., Author
Düngen, H. D., Author
Wagner, J., Author
Konen, T.1, Author              
von Ahsen, O., Author
Affiliations:
1Department of NanoBiophotonics, MPI for Biophysical Chemistry, Max Planck Society, ou_578627              

Content

show
hide
Free keywords: biomarkers; cardiovascular diseases; endothelial cells; endothelial progenitor cells; flow cytometry
 Abstract: Background: Endothelial dysfunction is involved in several cardiovascular diseases. Elevated levels of circulating endothelial cells (CECs) and low levels of endothelial progenitor cells (EPCs) have been described in different cardiovascular conditions, suggesting their potential use as diagnostic biomarkers for endothelial dysfunction. Compared to typical peripheral blood leukocyte subsets, CECs and EPCs occur at very low frequency. The reliable identification and characterization of CECs and EPCs is a prerequisite for their clinical use, however, a validated method to this purpose is still missing but a key for rare cell events. Objectives: To establish a validated flow cytometric procedure in order to quantify CECs and EPCs in human whole blood. Methods: In the establishment phase, the assay sensitivity, robustness, and the sample storage conditions were optimized as prerequisite for clinical use. In a second phase, CECs and EPCs were analyzed in heart failure with preserved (HFpEF) and reduced (HFrEF) ejection fraction, in arterial hypertension (aHT), and in diabetic nephropathy (DN) in comparison to age-matched healthy controls. Results: The quantification procedure for CECs and EPCs showed high sensitivity and reproducibility. CEC values resulted significantly increased in patients with DN and HFpEF in comparison to healthy controls. CEC quantification showed a diagnostic sensitivity of 90% and a sensitivity of 68.0%, 70.4%, and 66.7% for DN, HFpEF, and aHT, respectively. Conclusion: A robust and precise assay to quantify CECs and EPCs in pre-clinical and clinical studies has been established. CEC counts resulted to be a good diagnostic biomarker for DN and HFpEF.

Details

show
hide
Language(s): eng - English
 Dates: 2018-10-262019-01
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Method: Peer
 Identifiers: DOI: 10.1002/rth2.12158
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Research and Practice in Thrombosis and Haemostasis
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 3 (1) Sequence Number: - Start / End Page: 49 - 58 Identifier: -